Biotech Values

[ghmm]

I take the opposite approach especially as I am generally a longer term investor. The company's multiple to revenue's is getting quite attractive and they have a descent pipeline too. And if you are an optimist you think these issues will be resolved.

I'ld like the stock closer to 40 though (give or take) but perhaps if I did more DD I'ld see more value even at these prices.